AU2001248822A1 - Gd3-mimetic peptides - Google Patents
Gd3-mimetic peptidesInfo
- Publication number
- AU2001248822A1 AU2001248822A1 AU2001248822A AU4882201A AU2001248822A1 AU 2001248822 A1 AU2001248822 A1 AU 2001248822A1 AU 2001248822 A AU2001248822 A AU 2001248822A AU 4882201 A AU4882201 A AU 4882201A AU 2001248822 A1 AU2001248822 A1 AU 2001248822A1
- Authority
- AU
- Australia
- Prior art keywords
- amino acid
- mimetic peptides
- acid sequence
- deletion
- seq
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
- 102000004196 processed proteins & peptides Human genes 0.000 title abstract 2
- 108090000765 processed proteins & peptides Proteins 0.000 title abstract 2
- 125000003275 alpha amino acid group Chemical group 0.000 abstract 2
- 238000007792 addition Methods 0.000 abstract 1
- 125000000539 amino acid group Chemical group 0.000 abstract 1
- 230000037430 deletion Effects 0.000 abstract 1
- 238000012217 deletion Methods 0.000 abstract 1
- 230000037431 insertion Effects 0.000 abstract 1
- 238000003780 insertion Methods 0.000 abstract 1
- 239000000203 mixture Substances 0.000 abstract 1
- 230000009870 specific binding Effects 0.000 abstract 1
- 238000006467 substitution reaction Methods 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
- C07K7/04—Linear peptides containing only normal peptide links
- C07K7/08—Linear peptides containing only normal peptide links having 12 to 20 amino acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/0005—Vertebrate antigens
- A61K39/0011—Cancer antigens
- A61K39/001169—Tumor associated carbohydrates
- A61K39/001171—Gangliosides, e.g. GM2, GD2 or GD3
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/62—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being a protein, peptide or polyamino acid
- A61K47/64—Drug-peptide, drug-protein or drug-polyamino acid conjugates, i.e. the modifying agent being a peptide, protein or polyamino acid which is covalently bonded or complexed to a therapeutically active agent
- A61K47/646—Drug-peptide, drug-protein or drug-polyamino acid conjugates, i.e. the modifying agent being a peptide, protein or polyamino acid which is covalently bonded or complexed to a therapeutically active agent the entire peptide or protein drug conjugate elicits an immune response, e.g. conjugate vaccines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/04—Antineoplastic agents specific for metastasis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
- C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
- C07K14/4748—Tumour specific antigens; Tumour rejection antigen precursors [TRAP], e.g. MAGE
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
- C07K14/70596—Molecules with a "CD"-designation not provided for elsewhere
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/60—Medicinal preparations containing antigens or antibodies characteristics by the carrier linked to the antigen
- A61K2039/6031—Proteins
- A61K2039/6081—Albumin; Keyhole limpet haemocyanin [KLH]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Molecular Biology (AREA)
- Medicinal Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Immunology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Animal Behavior & Ethology (AREA)
- Biophysics (AREA)
- Biochemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Engineering & Computer Science (AREA)
- Genetics & Genomics (AREA)
- Pharmacology & Pharmacy (AREA)
- Gastroenterology & Hepatology (AREA)
- Epidemiology (AREA)
- Toxicology (AREA)
- Zoology (AREA)
- Oncology (AREA)
- Cell Biology (AREA)
- Virology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Peptides Or Proteins (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2000124259 | 2000-04-25 | ||
| JP2000-124259 | 2000-04-25 | ||
| PCT/JP2001/003443 WO2001081371A1 (fr) | 2000-04-25 | 2001-04-23 | Peptides gd3 mimetiques |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AU2001248822A1 true AU2001248822A1 (en) | 2001-11-07 |
Family
ID=18634414
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AU2001248822A Abandoned AU2001248822A1 (en) | 2000-04-25 | 2001-04-23 | Gd3-mimetic peptides |
Country Status (10)
| Country | Link |
|---|---|
| US (2) | US7341994B2 (fr) |
| EP (2) | EP1616875A1 (fr) |
| AT (1) | ATE356140T1 (fr) |
| AU (1) | AU2001248822A1 (fr) |
| CY (1) | CY1108570T1 (fr) |
| DE (1) | DE60127113T2 (fr) |
| DK (1) | DK1279677T3 (fr) |
| ES (1) | ES2283399T3 (fr) |
| PT (1) | PT1279677E (fr) |
| WO (1) | WO2001081371A1 (fr) |
Families Citing this family (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6998237B1 (en) * | 2002-07-11 | 2006-02-14 | Health Research, Inc. | GD3 peptide mimics |
| GB0514262D0 (en) * | 2005-07-12 | 2005-08-17 | Renovo Ltd | Promotion of epithelial regeneration |
| JP2009501200A (ja) * | 2005-07-12 | 2009-01-15 | レノボ・リミテッド | ＴＧＦ−βスーパーファミリーメンバーを含有する医薬組成物 |
| GB0604966D0 (en) * | 2006-03-11 | 2006-04-19 | Renovo Ltd | Medicaments and proteins |
| GB0604964D0 (en) * | 2006-03-11 | 2006-04-19 | Renovo Ltd | Protein folding |
| GB0604938D0 (en) * | 2006-03-11 | 2006-04-19 | Renovo Ltd | Proteins, nucleic acids and medicaments |
| GB0617816D0 (en) * | 2006-09-11 | 2006-10-18 | Renovo Ltd | Nucleic acids and methods of protein expression |
| WO2011022103A2 (fr) | 2009-08-18 | 2011-02-24 | Medical College Of Georgia Research Institute, Inc. | Épitopes de ganglioside pour traiter le syndrome de guillain-barré |
| US20120258519A1 (en) * | 2011-04-10 | 2012-10-11 | Therapeutic Proteins Inc. | Protein Harvesting |
| SG11201404991YA (en) | 2012-02-23 | 2014-09-26 | Stage Cell Therapeutics Gmbh | Chromatographic isolation of cells and other complex biological materials |
| WO2018197949A1 (fr) | 2017-04-27 | 2018-11-01 | Juno Therapeutics Gmbh | Reactifs particulaires oligomères et leurs méthodes d'utilisation |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5102663A (en) * | 1988-10-18 | 1992-04-07 | Sloan-Kettering Instutute For Cancer Research | Vaccine for stimulating or enhancing production of antibodies against 9-O-acetyl GD3 |
| AU669124B2 (en) | 1991-09-18 | 1996-05-30 | Kyowa Hakko Kirin Co., Ltd. | Process for producing humanized chimera antibody |
| JP3852945B2 (ja) | 1993-01-22 | 2006-12-06 | スローン − ケタリング・インスティテュート・フォー・キャンサー・リサーチ | Ｑｓ−２１を伴う、ガングリオシド‐ｋｌｈ複合体 |
| CU22420A1 (es) | 1993-12-29 | 1996-01-31 | Centro Inmunologia Molecular | Composicion vacunal para el desarrollo de una respuesta contra gangliosidos n glicolilados y su uso para el tratamiento del cancer |
| JPH10237098A (ja) | 1997-02-26 | 1998-09-08 | Immuno Japan:Kk | 糖脂質糖鎖レプリカペプチド |
| JPH10237099A (ja) | 1997-02-26 | 1998-09-08 | Immuno Japan:Kk | 糖脂質糖鎖レプリカペプチド |
| US6676946B2 (en) * | 1997-03-27 | 2004-01-13 | Institut Pasteur | Multiple antigen glycopeptide carbohydrate vaccine comprising the same and use thereof |
-
2001
- 2001-04-23 EP EP05015335A patent/EP1616875A1/fr not_active Withdrawn
- 2001-04-23 US US10/257,950 patent/US7341994B2/en not_active Expired - Fee Related
- 2001-04-23 AT AT01921990T patent/ATE356140T1/de active
- 2001-04-23 DE DE60127113T patent/DE60127113T2/de not_active Expired - Lifetime
- 2001-04-23 EP EP01921990A patent/EP1279677B1/fr not_active Expired - Lifetime
- 2001-04-23 PT PT01921990T patent/PT1279677E/pt unknown
- 2001-04-23 ES ES01921990T patent/ES2283399T3/es not_active Expired - Lifetime
- 2001-04-23 DK DK01921990T patent/DK1279677T3/da active
- 2001-04-23 AU AU2001248822A patent/AU2001248822A1/en not_active Abandoned
- 2001-04-23 WO PCT/JP2001/003443 patent/WO2001081371A1/fr active IP Right Grant
-
2007
- 2007-04-04 CY CY20071100467T patent/CY1108570T1/el unknown
- 2007-11-21 US US11/943,809 patent/US8017584B2/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| DE60127113D1 (de) | 2007-04-19 |
| EP1279677A4 (fr) | 2004-06-09 |
| ATE356140T1 (de) | 2007-03-15 |
| WO2001081371A1 (fr) | 2001-11-01 |
| EP1279677A1 (fr) | 2003-01-29 |
| DK1279677T3 (da) | 2007-05-07 |
| CY1108570T1 (el) | 2014-04-09 |
| US20060058226A1 (en) | 2006-03-16 |
| EP1616875A1 (fr) | 2006-01-18 |
| DE60127113T2 (de) | 2007-06-14 |
| US8017584B2 (en) | 2011-09-13 |
| US20080125374A1 (en) | 2008-05-29 |
| PT1279677E (pt) | 2007-06-12 |
| ES2283399T3 (es) | 2007-11-01 |
| US7341994B2 (en) | 2008-03-11 |
| EP1279677B1 (fr) | 2007-03-07 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DK0728148T3 (da) | Forbedrede immunogene sammensætninger mod humant gastrin 17 | |
| IL195338A (en) | An antibody comprising an FC variant containing amino acid replaces d or e at position 239, a medicament containing it and its use | |
| AU2196592A (en) | Causative agent of the mystery swine disease, vaccine compositions and diagnostic kits | |
| WO2003031464A3 (fr) | Remodelage et glycoconjugaison de peptides | |
| NZ503763A (en) | Antigenic compositions and vaccines comprising a high molecular weight (HMW) protein of Clamydia for therapeutic and prophylactic use | |
| AU2001290837A1 (en) | Use of a polypeptide comprising the extracellular domains of il-20rb for the treatment of inflammation | |
| WO1996034107A3 (fr) | Proteines antivirales, sequences d'adn codant pour ces proteines et utilisations | |
| BR9906927A (pt) | Proteìnas de neisseria meningitidis | |
| AUPP051497A0 (en) | Antimicrobial peptides | |
| AU4710499A (en) | Cyclic amino acid compounds, pharmaceutical compositions comprising same, and methods for inhibiting beta-amyloid peptide release and/or its synthesis by use ofsuch compounds | |
| WO1998004702A3 (fr) | Proteines, notamment proteines membranaires, d'helicobacter pylori, leur preparation et utilisation | |
| WO2002038592A3 (fr) | Peptides, leur fabrication et leur utilisation pour la liaison des immunoglobulines | |
| AU2001248822A1 (en) | Gd3-mimetic peptides | |
| AU5537096A (en) | Isolated frpb nucleic acid molecule and vaccine | |
| WO2006090090A3 (fr) | Epitopes de vih et composition pharmaceutique les contenant | |
| AU4263696A (en) | Peptides capable of binding to the gap protein sh3 domain, nucleotide sequences coding therefor, and preparation and use thereof | |
| AU3711597A (en) | A novel galanin receptor | |
| IL156041A0 (en) | Nucleic acid adjuvants | |
| IL139604A0 (en) | Novel peptides | |
| WO2001092468A3 (fr) | Nouvelles compositions pour l'expression du transporteur 1 d'histidine de peptide humain et leurs procedes d'utilisation | |
| AU3651997A (en) | Constructs and complexes of cyclin e | |
| AP9801399A0 (en) | Zona pellucida proteins for contraception. | |
| NZ511166A (en) | Genes that increase the production of HMG-CoA reductase inhibitor, ML-236B | |
| GB2283974A (en) | Allatostatins and their use | |
| EP1158052A4 (fr) | Gene de beta-primeverosidasde |